China Pharma Holdings, Inc.
CPHI
$1.43
$0.0151.06%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.97% | -28.31% | -53.84% | -52.50% | -40.97% |
| Total Depreciation and Amortization | -37.05% | -21.15% | -4.92% | 6.25% | 6.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.76% | 249.13% | 2,003.23% | 424.02% | 3,242.86% |
| Change in Net Operating Assets | 25.10% | 140.06% | 401.72% | 195.03% | 425.31% |
| Cash from Operations | 29.87% | -66.74% | 33.33% | -684.47% | 137.13% |
| Capital Expenditure | -72.98% | -43.26% | -233.91% | -215.27% | 82.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -200.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -254.25% | -452.30% | -2,437.39% | -215.27% | 39.26% |
| Total Debt Issued | -35.04% | -50.23% | -66.73% | 47.34% | 41.22% |
| Total Debt Repaid | 44.88% | 61.77% | 66.93% | 10.20% | -62.19% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -101.45% | -- | -- | -- |
| Cash from Financing | 80.19% | 88.70% | -62.52% | 108.10% | -246.87% |
| Foreign Exchange rate Adjustments | -332.39% | -1,020.69% | -307.84% | 430.82% | 124.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.66% | -29.91% | -31.50% | 9.10% | 87.90% |